Sglt-2 inhibitors for treating metabolic disorders in patients treated with neuroleptic agents
- 专利权人:
- BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- 发明人:
- 申请号：
- IL22946613
- 公开号：
- IL229466D0
- 申请日:
- 2013.11.17
- 申请国别(地区):
- IL
- 年份:
- 2014
- 代理人:
- 摘要：
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- SGLT-2 INHIBITORS FOR TREATING METABOLIC DISORDERS IN PATIENTS TREATED WITH NEUROLEPTIC AGENTS
- METHOD OF TREATING NEURODEGENERATIVE DISEASE
- AGENTS USEFUL FOR TREATING FRIEDREICH'S ATAXIA AND OTHER NEURODEGENERATIVE DISEASES
- PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC DISEASE
- METHODS FOR TREATING NEURODEGENERATIVE DISEASES AND FOR IDENTIFYING AGENTS USEFUL FOR TREATING NEURODEGENERATIVE DISEASES
